- Clinical Trials
- January 2024
- 60 Pages
Global
From €1138EUR$1,250USD£975GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1138EUR$1,250USD£975GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1138EUR$1,250USD£975GBP
- Book
- July 2018
- 488 Pages
- Book
- August 2019
- 416 Pages
Cathepsins are a family of proteolytic enzymes that are involved in the breakdown of proteins in the body. They are found in lysosomes, which are organelles that contain enzymes that break down proteins, lipids, and carbohydrates. Cathepsins are involved in a variety of physiological processes, including the regulation of cell growth and differentiation, the regulation of immune responses, and the degradation of extracellular matrix proteins. They are also involved in the development of diseases such as cancer, Alzheimer's, and cardiovascular disease.
The Cathepsin market is a rapidly growing sector of the enzyme industry. It is driven by the increasing demand for enzymes for research and therapeutic applications. The market is expected to grow due to the increasing prevalence of diseases such as cancer, Alzheimer's, and cardiovascular disease.
Companies in the Cathepsin market include Merck KGaA, Sigma-Aldrich, Abcam, Bio-Techne, and Thermo Fisher Scientific. Show Less Read more